2023³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ Á¦21Â÷ Á¤±âÇмú´ëȸ : 2023-04-29
±³À°ÀÏÀÚ : 2023-04-29
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽÇ
±³À°ÁÖÁ¦ : 2023³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ Á¦21Â÷ Á¤±âÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190
À̸ÞÀÏ : urology@urology.or.kr
±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í (»çÀüµî·Ï)ȸ¿ø: 20,000¿ø(¿¬È¸ºñ 10,000¿ø Æ÷ÇÔ)ºñȸ¿ø: 30,000¿ø°£È£»ç ¹× Àü°øÀÇ: ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 09:40~10:00 ºñ´¢±â°è ±â±¸ °ü·Ã°¨¿° ¹æÁö¸¦ À§ÇÑ ºñ Ç×»ýÁ¦Àû ¿¹¹æ¹ý ¹× °ü¸®¹ý À̽ſì(¼¿ïÀÇ·á¿ø)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 10:00~10:20 À߸øµÈ ¼Òµ¶Á¦ÀÇ °ü¸® ¹× ±â±¸¼Òµ¶À¸·Î ÀÎÇÑ °¡¼º À¯Çà ¹ß»ý ÇѽÃÇö(´Ü±¹´ëÇб³ õ¾Èº´¿ø)
Åä·Ð 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 10:20~10:30 ÁúÀÇ ÀÀ´ä ( )
ÈÞ½Ä 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 10:30~10:45 Coffee Break ( )
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 10:45~11:05 ¹æ±¤³» ¾à¹°ÁÖÀÔ ÀûÀÀÁõ ¹× Áúȯ¿¡ ´ëÇÑ ÀÌÇØ: Ç×¾ÏÁ¦, Hyaluronic acid & chondroitin ¹Ú´ëÇü(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 11:05~11:25 ¹æ±¤³» ¾à¹°ÁÖÀԽà ÁÖÀÇ»çÇ×, »ç¿ë ÈÄ Ã³¸®¹ý, ȯÀÚ ±³À° ±èÇöÁÖ(°í·Á´ëÇб³ ±¸·Îº´¿ø)
Åä·Ð 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 11:25~11:35 ÁúÀÇ ÀÀ´ä ( )
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 11:35~11:55 ¿Ü·¡ ºñ´¢³»½Ã°æ½Ç ±Ù¹«ÀÚ°¡ ¾Ë¾Æ¾ß ÇÒ ¹Ì»ý¹°ÇÐ ³ª¿õ(±¹¸³ÀÇ·á¿ø)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 11:55~12:15 ³»½Ã°æÀÚµ¿¼¼Ã´±â (AER)ÀÇ Æ¯Â¡°ú ¿î¿µ ¹®¾ç±â(Çѱ¹ ¿Ã¸²Çª½º)
Åä·Ð 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 12:05~12:15 ÁúÀÇ ÀÀ´ä ( )
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 12:00~12:15 Status of antibiotics resistance surveillance system in KAUTII À¯¼ºÇö(Àü³²ÀÇ´ë)
Åä·Ð 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 12:15~12:30 Panel Discussion ±èµ¿¼ö(°æÈñÀÇ´ë)
ÈÞ½Ä 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 12:30~13:30 Clinical Data & Real-Life practice of Nocdurna¢ç ±è¼öÁø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 13:30~13:50 Uropathogenic E. coli persistence during UTI: Pathologic Mechanism ÃÖÇØ¿õ(°í·Á´ë »ý¸í°úÇкÎ)
Åä·Ð 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 13:50~14:00 Panel Discussion ±ÇÅùÎ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 14:00~14:15 RECAP; Introduction of Korean version ¾È¼øÅÂ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 14:15~14:30 Nonantibiotic prevention strategy for recurrent UTI; The role of vaccine ½ÅÁÖÇö(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 14:30~14:45 Does the degree of pyuria alone can predict bacteriuria or urinary tract infection? ÃÖÁøºÀ(°¡Å縯ÀÇ´ë)
Åä·Ð 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 14:45~15:00 Panel Discussion ¿À¹Ì¹Ì(°í·ÁÀÇ´ë)
ÈÞ½Ä 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 15:00~15:15 Coffee Break ( )
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 15:15~15:30 Transrectal Prostate Biopsy: My Way to Reduce Complications Ãֱͺ¹(±¹¸³°æÂûº´¿ø)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 15:30~15:45 Transperineal Prostate Biopsy: My Way to Reduce Complications ÃÖ¿µÈ¿(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 15:45~16:00 Complications after prostate biopsy: How I respond Ãֽ±Ç(¼¿ïÀÇ·á¿ø)
Åä·Ð 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 16:00~16:15 Panel Discussion À¯±¸ÇÑ(°æÈñÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 16:15~16:30 Metgenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiom Analysis ±è¿õºó(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 16:30~16:45 Standardization of Urine Samples Collection for Microbiome Research ±è¿¬ÁÖ(´ë±¸ÆÄƼ¸¶º´¿ø)
Åä·Ð 04¿ù 29ÀÏ ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 16:45~16:55 Panel discussion ÃÖÀ翵(¿µ³²ÀÇ´ë)